Edited by
Stephen Neidle, The School of Pharmacy, University of London, UK
Stephen Neidle, The School of Pharmacy, University of London, UK
Description
The ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent
notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved
in specific cancers that are leading to effective medicines for at least some of the common solid tumours. Unique sections explain the
basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing
to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as
students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options.
Audience:
Translational researchers interested in cancer biology and medicine. Students in pharmacy, pharmacology, or medicinal and biological chemistry, as well as clinicians taking oncology options.
